Vesalius Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 02, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $75,000,000
Company Info
- Founding Year
- 2019
- Company Description
- Vesalius Therapeutics is focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.
- Market
- Drug Development
- Location
- Cambridge, MA, USA
- Coinvestors
- Flagship Pioneering